Lyme Disease

Testing

I've heard Lyme disease testing is unreliable. What are the available tests, and how reliable are they?


test-tubeOne of the most vexing issues in Lyme disease diagnosis is the debate over the role and reliability of currently available laboratory tests. Patients and their treating physicians may often turn to excessive or inappropriate testing after receiving negative results using the standard two-step testing method (ELISA and Western blot). This practice can result in conflicting evidence leading to misdiagnosis and unnecessary treatment while the real cause of illness remains obscure.

WHAT TESTS ARE AVAILABLE?
A variety of tests is available.  Many doctors who are unfamiliar with Lyme disease  use the Lyme testing available in their local laboratory.  This is usually the Lyme ELISA.  This tests measure a patient’s antibodies, a total of the  IgM and/or IgG, in response to exposure to the Lyme bacteria.  By today’s standards, these tests are not very sensitive. IGeneX lab in Palo -Alto California and Clongen Labs in Germantown, MD run a very specific and sensitive panel for the diagnosis of Lyme disease, including an IFA and Western Blot.

The Lyme IFA (performed as part of a Lyme Panel) detects IgG, IgM and IgA antibodies against B. burgdorferi (the spirochetal bacteria that causes Lyme disease). IgA antibodies are the first to become elevated. IgM antibody levels tend to rise above background levels about 2-3 weeks after infection and may remain elevated in case of prolonged disease. IgG's are the last antibodies to form.

The WESTERN BLOT (IgG and/or IgM) can visualize the exact antibodies you are making to specific parts of the Lyme bacteria.  In some cases the laboratory may be able to say that your “picture of Lyme antibodies” is consistent with early disease or with persistent/recurrent disease.  Not all patients have antibodies at all times when tested.  Antibodies are more commonly detected within the first year after infection, although re-infection may cause a significant rebirth of antibodies. At most, only 70% of patients have antibodies early, and the presence of antibodies alone does not make a diagnosis of disease. In many instances, a clinical diagnosis (diagnosis based on the history of the patient and their symptoms) from a Lyme Literate doctor is necessary in order to begin treatment immediately.

 

Disclaimer

The Midwest Lyme Foundation (MLF) and it's website is intended as a resource for people interested in learning about Lyme disease and other tick-borne illnesses. The information presented is for informational purposes only and is not intended as legal or medical advice regarding the treatment of any symptoms or disease. You should not use any information on the site to take the place of advice from your personal healthcare provider or other professional. Links to other sites are provided to facilitate research only and information on those sites is the opinion of those who publish the sites and is not necessarily that of Midwest Lyme Foundation.
You are here: About Lyme Testing